Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: August 2014
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. AstraZeneca AB v. Watson Laboratories Inc. et al.1:14-cv-01051; filed August 15, 2014 in the District Court of Delaware • Plaintiff: AstraZeneca AB• Defendants: Watson Laboratories Inc.; Actavis Inc.; Actavis LLC Infringement of U.S. Patent…
-
September 4, 2014 – "Patents and Export Control Compliance: Managing Risk and Avoiding Unintentional Violations — Minimizing Export Control Liability in Patent Application Preparation, Development and Analysis of Innovation, and Licensing" (Strafford) – 1:00 to 2:30 pm (EDT) September 7-9, 2014 – 42nd Annual Meeting (Intellectual Property Owners Association) – Vancouver, Canada September 11, 2014…
-
The Biotechnology Industry Organization (BIO) will be holding its second annual IP & Diagnostics Symposium from 8:15 am to 2:30 pm on September 26, 2014 at the Hilton Alexandria Old Town Hotel in Alexandria, VA. The Symposium will review the current patent law landscape and evaluate the impact on both the genetic diagnostics and biopharmaceutical…
-
The American Bar Association (ABA) Center for Professional Development and Section of Intellectual Property Law will be offering a live webinar entitled "Charting New Territory: Prosecution and Diligence Strategies in the Wake of the AIA" on September 25, 2014 from 1:00 to 2:30 pm (ET). Nicholas Mattingly of Mattingly & Malur, PC will moderate a…
-
The Institute for International Research (IIR) will be holding its 15th Annual Business of Biosimilars conference from October 20-22, 2014 in Boston, MA. The conference will offer presentations on the following topics: Pre-Conference Day — October 20: • Around the World in 1 Day: Emerging Markets Pre-Conference Summit• Women Leaders in Pharma Dinner Main Conference…
-
By Kevin E. Noonan — In the first of a pair of decisions issued last Friday, Ferring B.V. v. Watson Laboratories, Inc., the Federal Circuit affirmed a finding by the District Court that a generic company could moot ANDA litigation by amending its application to exclude practice of an infringing article. The case involved a…
-
By Michael Borella — Planet Bingo is the assignee of U.S. Patent Nos. 6,398,646 and 6,656,045, both directed to computer-implemented methods and systems for managing bingo games. Planet Bingo filed an infringement action in the United States District Court for the Western District of Michigan, alleging that VKGS infringed both patents. The District Court granted…
-
By Paul Cole* — Introduction It is strongly arguable that insofar as the USPTO's Myriad-Mayo Guidance[1] dismisses as non-eligible newly isolated substances (including small molecules), nucleotide sequences and microorganisms having new utility (US parlance) or producing new technical effects (European parlance) it is in conflict with the Agreement on Trade-Related Aspects of Intellectual Property Rights…
-
Proofread your claims before you sue! By Michael Greenfield — Even obvious clerical errors in patent claims can doom your lawsuit if not corrected before suit is filed. This was evident in H-W Technology, L.C. v. Overstock.com, Inc., issued July 11, 2014, where the Federal Circuit upheld the District Court's judgment in favor of defendant…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Aptalis Pharmatech Inc. et al. v. Apotex Inc. et al.1:14-cv-01038; filed August 11, 2014 in the District Court of Delaware • Plaintiffs: Aptalis Pharmatech Inc.; Ivax International GmbH• Defendants: Apotex Inc.; Apotex Corp. Infringement…
Patent Docs 